Literature DB >> 6640562

Cardiac rehabilitation after acute myocardial infarction. 9-year controlled follow-up study.

O Román, M Gutierrez, I Luksic, E Chavez, A L Camuzzi, E Villalón, C Klenner, F Cumsille.   

Abstract

Since the effect of cardiac rehabilitation (CR) on morbidity and mortality due to myocardial infarction on a long-term basis appears controversial, a controlled follow-up survey was conducted from 1973 to 1981 in 193 patients suffering a first acute myocardial infarction (AMI). The admission criteria included absence of contraindications to CR during the acute phase of AMI. Patients were divided into two matched groups: 93 patients followed a CR program, exercising 30 min three times a week (means 42; range 6-108 months) and the remaining 100 patients served as controls. Age, sex, location and extension of the myocardial damage, frequency of coronary risk factors and complications during the acute phase were comparable. At 9 years, there were 24 cardiac deaths (15 AMI, 7 sudden deaths and 2 heart failures) among the controls and 13 deaths in the CR group (7 AMI, 4 sudden deaths, 2 heart failures), mortality rates being 5.2 and 2.9% per year (p less than 0.1 greater than 0.05; NS), respectively. There were 23 recurrent AMI in the control versus 16 in the CR patients, the corresponding rates being 4.9 and 3.6% per year, respectively (NS). Nor were any differences observed in the incidence of myocardial ischemia, severe arrhythmias or cerebrovascular strokes between both groups, but the appearance of angina was significantly lower in the CR group compared with the controls (5.1 and 10.2% per year, respectively, p less than 0.005). It is concluded that CR on a long-term basis seems to improve the mortality rate of AMI and to reduce the frequency of anginal pain.

Entities:  

Mesh:

Year:  1983        PMID: 6640562     DOI: 10.1159/000173598

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  9 in total

Review 1.  Exercise in cardiac rehabilitation.

Authors:  H J Bethell
Journal:  Br J Sports Med       Date:  1999-04       Impact factor: 13.800

2.  Exercise after myocardial infarction: appraisal of the literature.

Authors:  E V Dunn
Journal:  Can Fam Physician       Date:  1989-09       Impact factor: 3.275

Review 3.  Cardiac rehabilitation exercise programme. Compliance and compliance-enhancing strategies.

Authors:  N B Oldridge
Journal:  Sports Med       Date:  1988-07       Impact factor: 11.136

Review 4.  Exercise-based cardiac rehabilitation for coronary heart disease.

Authors:  Grace Dibben; James Faulkner; Neil Oldridge; Karen Rees; David R Thompson; Ann-Dorthe Zwisler; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2021-11-06

Review 5.  Exercise-based cardiac rehabilitation for coronary heart disease.

Authors:  Lindsey Anderson; David R Thompson; Neil Oldridge; Ann-Dorthe Zwisler; Karen Rees; Nicole Martin; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2016-01-05

6.  Efficacy of Different Types of Exercise-Based Cardiac Rehabilitation on Coronary Heart Disease: a Network Meta-analysis.

Authors:  Tian-Li Xia; Fang-Yang Huang; Yong Peng; Bao-Tao Huang; Xiao-Bo Pu; Yong Yang; Hua Chai; Mao Chen
Journal:  J Gen Intern Med       Date:  2018-09-13       Impact factor: 6.473

7.  Cardiac rehabilitation: a comprehensive review.

Authors:  Scott A Lear; Andrew Ignaszewski
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

Review 8.  The Contribution of Individual Exercise Training Components to Clinical Outcomes in Randomised Controlled Trials of Cardiac Rehabilitation: A Systematic Review and Meta-regression.

Authors:  Bridget Abell; Paul Glasziou; Tammy Hoffmann
Journal:  Sports Med Open       Date:  2017-05-05

Review 9.  Comparative Effectiveness of the Core Components of Cardiac Rehabilitation on Mortality and Morbidity: A Systematic Review and Network Meta-Analysis.

Authors:  Nader N Kabboul; George Tomlinson; Troy A Francis; Sherry L Grace; Gabriela Chaves; Valeria Rac; Tamara Daou-Kabboul; Joanna M Bielecki; David A Alter; Murray Krahn
Journal:  J Clin Med       Date:  2018-12-04       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.